Difference between revisions of "Normative:Coronavirus vaccine"
(new addition) |
(formatting) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
* COVID-19 vaccine | * COVID-19 vaccine | ||
*SARS-CoV-2 vaccine | |||
* | * | ||
===Definition=== | ===Definition=== | ||
' COVID-19vaccine ' means an immunological medicinal product indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 | 'COVID-19vaccine' means an immunological medicinal product indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2. | ||
<small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953</small> | <small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953</small> | ||
===Examples=== | ===Examples=== | ||
<blockquote>The vaccination certificate should contain only the information necessary to clearly identify the holder as well as the '''COVID-19 vaccine''' administered, the number of doses, and the date and place of vaccination.</blockquote><small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953</small> <blockquote>In addition, Member States have the possibility to allow non-essential travel to the EU of third-country nationals who have received the last recommended dose of a '''COVID-19 vaccine''' that has completed the WHO emergency use listing process (7) </blockquote><small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021H0961</small> | <blockquote>The vaccination certificate should contain only the information necessary to clearly identify the holder as well as the '''COVID-19 vaccine''' administered, the number of doses, and the date and place of vaccination.</blockquote><small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953</small> <blockquote>In addition, Member States have the possibility to allow non-essential travel to the EU of third-country nationals who have received the last recommended dose of a '''COVID-19 vaccine''' that has completed the WHO emergency use listing process (7) </blockquote><small>Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021H0961</small><blockquote>People with HIV should receive '''SARS-CoV-2 vaccines''' , regardless of their CD4 count or HIV viral load, because the potential benefits outweigh the potential risks (AIII).</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
===Collocations=== | ===Collocations=== | ||
| Line 18: | Line 19: | ||
* mRNA COVID-19 vaccine | * mRNA COVID-19 vaccine | ||
* authorized COVID-19 vaccine | * authorized COVID-19 vaccine | ||
*SARS-CoV-2 vaccine effectiveness | |||
* | * | ||
| Line 23: | Line 25: | ||
* COVID-19 vaccine: 733 | * COVID-19 vaccine: 733 | ||
*SARS-CoV-2 vaccine: >1000 | |||
===Note=== | ===Note=== | ||
" | "Coronavirus vaccine" does not appear in the corpus. | ||
Latest revision as of 19:09, 7 March 2022
Normative
Synonyms
- COVID-19 vaccine
- SARS-CoV-2 vaccine
Definition
'COVID-19vaccine' means an immunological medicinal product indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2.
Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953
Examples
The vaccination certificate should contain only the information necessary to clearly identify the holder as well as the COVID-19 vaccine administered, the number of doses, and the date and place of vaccination.
Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953
In addition, Member States have the possibility to allow non-essential travel to the EU of third-country nationals who have received the last recommended dose of a COVID-19 vaccine that has completed the WHO emergency use listing process (7)
Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021H0961
People with HIV should receive SARS-CoV-2 vaccines , regardless of their CD4 count or HIV viral load, because the potential benefits outweigh the potential risks (AIII).
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Collocations
- mRNA COVID-19 vaccine
- authorized COVID-19 vaccine
- SARS-CoV-2 vaccine effectiveness
Keyness
- COVID-19 vaccine: 733
- SARS-CoV-2 vaccine: >1000
Note
"Coronavirus vaccine" does not appear in the corpus.